期刊文献+

马拉色菌对三种唑类抗真菌药的体外药敏试验 被引量:2

In vitro activity of three kinds of azole antifungal agents against Malassezia species
暂未订购
导出
摘要 目的:探讨马拉色菌标准株和临床分离株对酮康唑、伊曲康唑和氟康唑的体外敏感性。方法:用生理生化及形态学方法对临床分离的马拉色菌菌株进行菌种鉴定。参照美国临床实验室标准委员会(NCCLS)制订的M27-A方案中酵母菌微量稀释法,检测7种马拉色菌标准株和42株临床分离株对酮康唑、伊曲康唑和氟康唑的最小抑菌浓度(MIC)。结果:42株马拉色菌临床分离株包括5个种,分别是合轴马拉色菌、糠秕马拉色菌、钝形马拉色菌、球形马拉色菌、限制性马拉色菌。用M27-A方案中酵母菌微量稀释法测定3种唑类抗真菌药对7种马拉色菌标准株和42株临床分离株的敏感性由高到低分别为:伊曲康唑、酮康唑、氟康唑。结论:马拉色菌属的各菌种对酮康唑、伊曲康唑和氟康唑的敏感性存在差异;M27-A方案中酵母菌微量稀释法可用于马拉色菌的体外药敏试验。 Objective: To evaluate the in vitro activities of ketoconazole, itraconazole and fluconazole against 7 standard strains and 42 clinical isolates of Malassezia species. Methods: The isolated colonies of Malassezia were identified according to their biochemical, physiological and morphological characteristics. In vitro activities of ketoconazole, itraconazole and fluconazole against 7 standard strains and 42 clinical isolates of Malassezia species were tested by M27-A microdilution method recom mended by National Committee for Clinical Laboratory Standards (NCCLS). Results: Five species,including M. sympodialis, M. fur fur, M. obtusa, M. globosa, and M. restricta, were identified out of 42 clinical isolates of Malassezia. It was found that the order of 3 azole antifungal agents from high to low susceptibility to Malassezia species was itraconazole〉 ketoconazole〉fluconazole. Conclusion: The susceptibilities of Malassezia species to ketoconazole, itraconazole , and fluconazole are different. Microdilution method from M27-A is suitable for testing the susceptibility of Malassezia in vitro.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2005年第11期1277-1279,共3页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30471566)
关键词 马拉色菌 抗真菌药 微生物敏感性试验 Malasssezia antifungal agents microbial sensitivity tests
  • 相关文献

参考文献9

二级参考文献9

共引文献97

同被引文献36

  • 1王晓玲,赵天恩,张喜芹.简体中文版皮肤病生活质量指标信度和效度初探[J].中华流行病学杂志,2004,25(9):791-793. 被引量:275
  • 2陈丽娜,陈江汉,徐红,赖建平,陈爱华,廖万清,温海.临床分离皮肤癣菌289株体外药敏试验分析[J].第二军医大学学报,2005,26(3):337-339. 被引量:7
  • 3欧春荣.2%酮康唑乳膏治疗马拉色菌毛囊炎40例疗效观察[J].岭南皮肤性病科杂志,2005,12(3):240-240. 被引量:1
  • 4郑晓晖,夏修蛟,王志东,许爱娥.七种抗真菌药物对马拉色菌的体外抑菌试验研究[J].中国皮肤性病学杂志,2006,20(2):75-76. 被引量:11
  • 5Scheinfeld N. Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations [ J ]. Drugs Today( Barc), 2008,44(5 ) :369-380.
  • 6Smith EB. Ketoconazole 2% cream[ J]. Seminars in Dermatology, 1987,6( 1 ) :62-65.
  • 7Gupta AK, Kohli Y. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifunzal activity [J].Br J Dermatol. 2003,149 ( 2 ) :296-305.
  • 8Van Gerven F, Odds FC. The anti- Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents : bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole [ J ]. Mycoses, 1995,38 (9-10) : 389-393.
  • 9Borgers M. The role of ketoconazole in seborrheic dermatitis[ J]. Cutis,2007,80(4) :359-363.
  • 10Van Cutsem J, Van Gerven F, Cauwenbergh G,et al. The anti- inflammatory effects of ketoconazole: a comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea pigs [J]. J Am Acad Dennatol,1991,25(2 pt 1 ) :257-261.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部